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Abstract 
 
Background: Rate of ICD implantations is increasing in patients with advanced heart failure. Despite 
clear guideline recommendation, discussions addressing deactivation occur infrequently.  
 
Aim: To explore patient and professional factors that impact perceived likelihood and confidence of 
healthcare professionals to discuss ICD deactivation.   
 
Methods and Results: Between 2015 and 2016, an international sample of 262 healthcare 
professionals (65% nursing; 24% medical) completed an online factorial survey, encompassing  
demographic questionnaire and clinical vignettes. Each vignette had nine randomly manipulated and 
embedded patient-related factors, considered as independent variables, providing 1,572 unique 
vignettes for analysis.  These factors were determined through synthesis of a systematic literature 
review, retrospective case note review and qualitative exploratory study. Results showed most 
healthcare professionals agreed deactivation discussions should be initiated by a cardiologist (95%, 
n=255) or specialist nurse (81%, n=215). In terms of experience, 84% (n=53) of cardiologists but only 
30% (n=50) of nurses had previously been involved in a deactivation decision. Healthcare 
professionals valued patient involvement in deactivation decisions, however only 50% (n=130) 
actively involved family members. Five out of nine clinical factors were associated with an increased 
likelihood to discuss deactivation including advanced age, severe heart failure, presence of 
malignancy, receipt of multiple ICD shocks and more than three hospital admissions during the 
previous year. Furthermore, nationality and discipline significantly influenced likelihood and 
confidence in decision-making.  
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Conclusions: Guidelines recommend healthcare professionals discuss ICD deactivation, however 
practise is sub-optimal with multifactorial factors impacting on decision-making. The role and 
responsibility of nurses in discussing deactivation requires clarity and improvement.      
 
Keywords: Defibrillators, implantable; Heart Failure; Decision-making; Survey; Terminal care 
 
Introduction 
 
There is a gap between guideline recommendations and everyday clinical practice concerning 
Implantable Cardioverter Defibrillator (ICD) deactivation1. Increasing rates of ICD implantation and an 
improved life expectancy with many elderly living with co-morbidities, intensifies the need for clarity 
on the role of the ICD in the advanced stages of any illness.  A recent study found that one in four 
patients received futile and painful shocks from the device shortly before death2. Many factors are 
implicated including patients’ lack of knowledge on the device and deactivation, their life-saving 
perception of the ICD3 and the dialogue about deactivation characterised as “too little, too late”1.    
International and interdisciplinary discrepancies exist on who should discuss deactivation and 
when such discussions should occur4,5. In a survey of 384 Heart Rhythm Society members6 
deactivation was considered by most professionals questioned to be permissible if aligned with the 
patient’s (78%, n=296) and/or carer’s (72%, n-278) wishes. Studies have found nurses reluctant to 
engage in discussions, assigning sole responsibility for discussing and ultimately decision-making 
regarding deactivation with medical professionals1,4. In a recent position statement from the Council 
on Cardiovascular Nursing and Allied Professionals (CCNAP), the varied role of healthcare 
professionals across Europe was highlighted7, reinforcing the need to improve international research 
and collaboration, as well as improve knowledge on country specific data to facilitate the development 
of strategies to improve the practice of ICD deactivation across healthcare systems. As the number 
of patients with an ICD increases, there is an urgent need to address this clinical concern to ensure 
quality of life during the palliative stage of illness.       
 
Aim 
 
To explore patient and professional factors that impact perceived likelihood and confidence of 
healthcare professionals to discuss ICD deactivation. 
 
Methodology 
 
Design 
This cross-sectional factorial design study conformed to the Declaration of Helsinki8 and was 
approved by the local research ethics committee.  Originally developed by Rossi and Nock (1982)9, 
the factorial survey combines the strengths of random manipulation of variables with the 
generalizability of a survey. The design has been successfully used in studies, for example, nurses’ 
use of physical restraints10, indicators of acute deterioration11 and nurses’ judgement of self-neglect12.  
Though a systematic and iterative process13, twenty-one factors associated with ICD deactivation 
were generated from a systematic literature review14, a retrospective case note review1 and qualitative 
exploration (Refer Appendix 1). These factors were repeatedly reviewed and refined by four 
methodological and three clinical experts for content validity, until there were nine orthogonal and 
clinically relevant patient-related factors or variables15-17 for inclusion within the survey.  
 
Study instrument 
The survey was distributed electronically using a secure IT platform to ensure complete anonymity. 
Participants received a short demographic questionnaire, a standard vignette, followed by six unique 
clinical vignettes (Refer Appendix 2).  
 
Questionnaire 
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Demographic and experiential data were collected. Healthcare professionals were presented with 
short statements and asked to record on a zero to ten Likert scale the probability of referral for ICD 
deactivation. A score of zero indicated the patient would not be referred, while a score of ten indicated 
the healthcare professional would refer for deactivation.  
 
Factorial survey 
The nine patient-related factors or Independent Variables were: Age, Gender, Previous Discussion, 
Heart Failure Severity, Comorbidities, Number of Admissions, Number of Shocks, Treatment Intent 
and Social Support. Each factor had between three to five levels. Participants responded to a standard 
vignette that allowed the researcher to assess their engagement and comprehension of the 
instrument’s scoring system. This was followed by six unique vignettes, in which the nine evidence-
based factors had been randomly allocated. Participants’ responses to vignettes were captured by 
two dependent variables. (Refer Table 1). A total of 200 vignettes were checked by the researcher 
(LH) prior to a pre-test with ten healthcare professionals with clinical experience of patients with an 
ICD. This determined time-to-complete the survey and content validity.  
 
Table 1: Example of a clinical vignette (clinical factors or independent variables in italics) & two 
dependent variables 
  
 
You review a 59-year-old man with moderate heart failure (NYHA III) and bowel cancer. He 
has had one admission over the past year and has experienced more than one shock. 
Medical records show no previous discussion about deactivation with documented 
management plan to be referral for cardiac transplant. The patient lives with family who 
share healthcare decisions. 
      Dependent variables: 
1. What is the likelihood that you would discuss ICD deactivation with this patient? 
2. How confident are you in the decision you have just made?  
 
 
Sample 
Access to a convenience sample of healthcare professionals involved in the daily management of 
patients with an ICD was facilitated through professional organisations, for example Irish Cardiac 
Society (n=350), British Society of Heart Failure (n=921) and CCNAP (n=2900). The survey was 
promoted on websites, news bulletins and at conference presentations. Emails inviting participation 
were sent by the international research team.  
 
Statistical Analysis 
Data were analysed using SPSS (version 22) with descriptive and inferential statistics. The framework 
developed by Miller18 informed the analysis, which was conducted at two levels, ‘patient factors or 
independent variables’ (within vignettes) followed by ‘professional factors’ (questionnaire), with 
significance p=<0.05. The recommended analysis for factorial surveys17 is Multivariate Regression 
and ANOVA, which examines the relationship between each independent variable and dependent 
variable. Multivariate Regression, ANOVA and Independent T-tests examined each professional 
factor against each dependent variable. Given the high level of statistical tests conducted, multiplicity 
was an issue. Therefore a ‘false discovery rate’ analysis19 was conducted and p-values recalibrated 
accordingly.      
 
Results 
 
A total of 457 international professionals accessed the web-link; 262 completed the survey (57% 
completion rate) which included a questionnaire, standard vignette and six unique vignettes (1,834 
total vignettes; 1,572 unique vignettes). 
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Demographic Questionnaire  
The sample consisted of predominately British residents (60%, n=161), followed by representation 
from Europe (21%, n=56) and America (17%, n=45). Participants were predominately female, 
specialist nurses and those with at least six years (70%, n=182) experience. Demographic details 
presented in Table 2. 
 
Table 2: Demographic and professional characteristics of participants (n=262) 
Characteristics N (%) or Mean ± SD 
Gender 
Female 
 
193 (74%)  
Age (years) 45.8 ±8.9 Range 26-65 years 
Discipline 
Nursing 
Medical 
Cardiac Physiologist (Technician)  
 
  170 (65%) 
    63 (24%) 
    29 (11%) 
Current Role 
Specialist Nurse 
Cardiologist 
Cardiac Physiologist 
Other (i.e .general nurse/physician, 
physiotherapist) 
Electro-Physiologist 
 
 150 (57%) 
  46 (18%) 
  29 (11%) 
  24 (9%) 
  13 (5%) 
Time in Current Role 
Less than 1 year 
1-5 years 
6-10 years 
More than 10 years 
 
  11 (4%) 
  68 (26%) 
  59 (23%) 
123 (47%) 
 
Attitude towards the deactivation discussion 
Most healthcare professionals stated that cardiologists (97%, n=255) or specialist nurses (82%, 
n=215) should initiate discussions concerning ICD deactivation, with some also placing responsibility 
on primary care physicians (63%, n=166). All physicians supported this view, as did the majority of 
nurses (96%, n=163). Four British nurses, two American and one nurse from Europe believed the 
discussion could be initiated by a specialist nurse.  Healthcare professionals agreed that deactivation 
should be discussed - prior to device implantation (81%, n=213), when the patient’s condition 
deteriorates (83%, n=218) and at the palliative stage (78%, n=205). Figure 1 demonstrates that 
nurses (84%, n= 167) were more in favour of discussing ICD deactivation prior to implantation, 
compared to physicians (73%, n=46). In contrast, a higher percentage of physicians stated ICD 
deactivation should be discussed when patient’s care becomes palliative (86%, n=54) compared to 
nurses (76%, n=151). The presence of a deactivation policy was not associated with the likelihood of 
discussing deactivation (p=0.8), however healthcare professionals were more confident making this 
decision when a deactivation policy was present (p=0.03). 
 
Figure 1: Percentage of healthcare professionals recommending discussion at three time-points 
(n=262)  
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 The 
majority of professionals (87%, n=232) expressed that they did not have ethical or legal concerns 
concerning ICD deactivation. Independent T-test found no significant difference in attitude between 
European professionals, compared to American colleagues (p=0.36).    
 
Experience of involvement in the deactivation decision 
Nearly all healthcare professionals (97%, n=255) stated the patient should be included in the decision 
to deactivate their device, but only 50% (n=130) actively involved family members. There was diversity 
of experience between disciplines with 84% (n=53) of physicians previously involved in an ICD 
deactivation decision, compared to approximately one third (30%, n=50) of nurses and 14% (n=4) of 
cardiac physiologists.     
Healthcare professionals ranked their likelihood to refer patients for deactivation, based on six 
clinical statements. Mean values for each statement are documented in Table 3. Results indicate 
healthcare professionals are more likely to consider deactivation when a Do Not Resuscitate (DNR) 
order is placed, or when the patient requests comfort care. 
  
Table 3:  Healthcare professionals’ likelihood to refer for deactivation on Likert scale of 0-10 (n=262) 
 
Factorial Survey  
A total of 262 participants reported on one standard and six randomly generated vignettes, generating 
1,834 vignettes for analysis. Responses to the standard vignette were consistent for both outcome 
variables - ‘Likelihood of discussing deactivation’ (M=2.60, SD ±2.11) and ‘Confidence in the decision 
made’ (M=7.96, SD± 2.8). The standard vignette was not included in further analysis, rendering 1,572 
unique vignettes for Multiple Regression and ANOVA. False discovery rate analysis found one 
variable- number of admission (p=0.04) which when the p-value was adjusted, was no longer 
significant (p=0.07) (see Table 4). 
 
Patient factors that impact perceived likelihood and confidence to discuss ICD deactivation 
The nine independent variables explained 10% of the variance (Adjusted R2=0.10) in healthcare 
professionals’ likelihood of discussing deactivation. Five independent variables were significantly 
related to their likelihood of discussing deactivation- patient age, comorbidities, number of 
admissions, number of shocks experienced and heart failure severity. Healthcare professionals were 
more likely to discuss deactivation when the patient was of an advanced age (p=0.01), had a history 
Likert Scale  DNR 
Actioned 
Comfort 
care 
Palliative 
care 
referral  
Requests 
deactivation 
Less than 
12 months 
to live 
Multiple 
shocks 
Mean score  9.89 9.70 8.75 8.23 7.56 6.31 
Standard 
Deviation  
±1.86 ± 2.03 ± 2.39 ± 2.80 ±2.88 ± 3.52 
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of bowel cancer (p<0.01), more than three hospital admissions over the preceding twelve months 
(p<0.01), receipt of multiple shocks (p<0.01), and experienced severe (NYHA IV) heart failure 
symptoms (p<0.01).   
The relationship between the nine independent variables and professional confidence was 
found to be significant (p<0.01), however it could only explain 1% of the variance (Adjusted R2 
=0.013). Three factors had a significant impact, with healthcare professionals more confident in 
decision-making when the patient had a previous in-depth discussion on deactivation (p=0.04), 
experienced severe heart failure (p=0.02) or he/she lived with and was supported by family in 
healthcare decisions (p=0.03). Table 4 outlines the relationship between independent variables and 
dependent variables. 
 
Table 4: Independent Variables & Professional Characteristics with Dependent Variables (n=262)  
Independent & 
Professional  
variables   
Levels  Likelihood to discuss 
deactivation M±SD  
Confidence in the 
decision made 
M±SD 
Patient age 39 yrs 
59 yrs 
75 yrs 
86 yrs 
5.99 ± 3.29 
6.37± 3.13 
6.96± 3.05 
7.36 ± 2.96  (p=0.01) 
Not significant  
Comorbidities Bowel cancer  
Renal failure 
Dementia 
7.38± 2.8    (p<0.01) 
6.78 ± 3.04 
5.96 ± 3.38 
Not significant  
Number of 
Admissions 
No admissions 
1 admission 
>3 admissions 
Not significant  Not significant  
Number of 
shocks 
experienced  
No experience of shock 
Experienced >1 shock 
Experienced multiple 
shocks 
6.11 ± 3.18 
6.60 ± 3.10 
6.95 ± 3.20  (p<0.01) 
No significant  
Heart Failure 
severity  
NYHA II 
NYHA III 
NYHA IV 
5.69 ± 3.21 
6.44 ± 3.12 
7.48 ± 2.95  (p<0.01) 
8.17 ± 2.35 
8.28 ± 2.34 
8.54 ± 2.28 (p=0.02) 
Previous 
Discussion  
No previous discussion 
Brief previous 
discussion 
Previous in-depth 
discussion  
Not significant  8.26 ± 2.41 
8.17 ± 2.30 
8.57 ± 2.24 (p=0.04) 
Social support Lives alone 
Lives alone with support 
Lives with family who 
share decisions 
Not significant  8.15 ± 2.39 
8.36 ± 2.27 
8.50 ± 2.31 (p=0.03) 
Country of Origin  Ireland & Europe 
UK 
US 
6.33 ± 3.150 
6.41 ± 3.07 
7.32 ± 3.50 (p<0.01) 
8.39 ± 2.19 
8.07 ± 2.35 
9.19 ± 2.26 (p<0.01) 
Discipline Medical  
Nursing 
Healthcare Science  
6.88 ± 3.35 (p=0.04) 
6.63 ± 3.08 
5.46 ± 3.20  
8.98 ± 1.96 (p=0.02) 
8.14 ± 2.45 
8.17 ± 2.06  
Times initiated 
discussion  
1-10 times 
10-25 times 
Multiple 
6.47 ± 3.02 
6.88  ± 3.25 
7.93 ± 3.31 (p<0.01)  
8.36 ± 2.21 
8.69 ± 2.08 
9.90 ± 1.39 (p<0.01) 
Time in Current 
role  
<1 year 
1-5 years 
6-10 years 
Not significant  7.84 ±  2.33 
8.08 ± 2.25 
8.43 ± 2.35 
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[ANOVA posthoc with adjusted p values] 
 
Professional factors that impact perceived likelihood and confidence to discuss ICD deactivation   
Six healthcare professional characteristics, namely country of origin, gender, discipline, time in current 
role, times initiated a deactivation discussion, ethical and legal concerns explained 3% of variance 
(Adjusted R2 =0.026) in likelihood of discussing deactivation. Variables of country of origin, discipline 
and times initiated deactivation discussion had a significant impact (p<0.01), for example, healthcare 
professionals were more likely to discuss deactivation if American (p<0.01), being a physician 
(p=0.04) and had initiated a discussion concerning deactivation on multiple occasions (p<0.01). Mean 
results of likelihood to discuss and professional characteristics are graphically displayed in Figure 2. 
 
Figure 2: Professional Characteristics and likelihood to discuss deactivation (n=262) 
 
 
The six professional characteristics explained 6% (Adjusted R2=0.055) of the variance, with 
all six factors significantly impacting (p<0.01) professionals’ confidence. For example, male 
healthcare professionals (p<0.01), professionals who were American (p<0.01), being a physician 
(p=0.02), more than six years in current post (p=0.03), initiated a deactivation discussion on multiple 
occasions (p<0.01), and have no ethical or legal concerns (p=0.01) were more confident in their 
decision making (Refer to Table 4). Mean results of confidence in decision made and professional 
characteristics are graphically presented in Figure 3.  
>10 years 8.47 ± 2.36 (p=0.03) 
Gender Male  
Female  
Not significant 8.84 ± 1.98 (p<0.01) 
8.15 ± 2.43 
Ethical or legal 
concerns  
Yes 
No 
Not significant  7.85 ± 2.64 
8.41 ± 2.28 (p=0.01) 
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Figure 3: Professional Characteristics and confidence in decision (n=262) 
 
 
Discussion 
 
This study’s unique methodology, through the random manipulation of patient-related factors aimed 
to confidently extrapolate their influence on clinical decision-making. Results illustrate a number of 
disparities in clinical practice2, despite international guideline recommendations20,21,22.  Five patient-
related factors and three healthcare professional factors influenced the likelihood that ICD 
deactivation would be discussed. The percent of variance predicted by our regression models was 
small, however on comparison to similar published factorial studies23,24 confidence can be placed on 
our findings. Physicians and more specifically cardiologists, accepted the responsibility to discuss and 
decide whether to deactivate an ICD, more than nurses. Finally, there was a consensus of agreement 
among healthcare professionals on the need to more actively include patients and family members in 
discussions and decisions that affect care.   
 
Cross country variation 
The study confirmed professional practice was influenced by several key clinical indicators, which 
support and extend published findings of a professional survey conducted by Marinskis and van Erven 
(2010)25. Their study examined professional attitudes from 47 centres of the European Heart Rhythm 
Association’s (EHRA) research network and found 83% would consider deactivation if the patient was 
experiencing multiple shocks, however only 4% of professionals routinely discussed deactivation. The 
reluctance to discuss palliative issues varies internationally, as illustrated in the study by Voohees et 
al.26. Just under half of Italian physicians (43%) would not inform competent patients of their 
prognosis, compared to most Swedish physicians (89%). In addition, physicians in Belgium (89%) 
were more likely (p<0.01) to disclose information to next of kin, compared to Dutch physicians (48%). 
In contrast, a survey of Dutch and Swedish nurses (n=275) found Dutch nurses more willing to discuss 
prognosis in comparison to Swedish nurses (p<0.01)4. Finally a British study found 53% (n=23) of 
dying patients with an ICD had a discussion about prognosis, with a third (n=17) of these discussions 
broaching the subject of deactivation1. 
This study found American physicians and nurses were more apt to discuss deactivation in 
comparison to European colleagues, a result that both supports27 and conflicts28 with previous 
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evidence. An American study by Kelley et al.27 surveyed 558 physicians and found when presented 
with five clinical scenarios, more than half (56% - 83%) would initiate a discussion concerning 
deactivation. In contrast, Dunlay et al.28 reported a majority (52%; n=49) of physicians would hesitate 
to discuss palliative issues. Reasons included personal discomfort (11%), fear of destroying hope 
(9%), or lack of time (8%). In this study the majority of professionals had no ethical or legal concerns29, 
however the minority who had (13%) were less confident in decision-making. There is increasing 
evidence that nurses30 and physicians31 can experience moral distress, with a detrimental impact on 
clinical care. Moral distress is the result of perceived aggressive or “futile” care, therefore highlighting 
the need for additional support for professionals when managing dying patients with an ICD.   
In summary, there was cross country variation in healthcare professionals’ decision to discuss 
ICD deactivation, as evident in this study and the published literature26,27.     
 
Medical dominance of the final decision  
The discipline with highest representation within the sample was nursing (65%, n=168), indicating 
their predominance in clinical settings, high level of involvement with patients with an ICD and 
increased willingness to participate in the survey32,33. Specialist nurses were patients’ main 
professional support, possessing evidence-based knowledge and skills to address palliative 
concerns4.  This is reflected in our results whereby most professionals (81%, n=215) felt specialist 
nurses had the necessary attributes to initiate a discussion about deactivation. The data however 
does expose a lack of nursing contribution to the final decision concerning deactivation, as only 30% 
(n=50) of nurses within the sample reported previous involvement. This could be explained by the 
structure of the healthcare system34 and the traditional role of physicians to diagnose and make 
treatment decisions. In addition, it may also be explained by the findings illustrated in Figure 1, 
whereby nurses perceived the best time to discuss deactivation was prior to implant and not when 
the patient required palliative care, the reverse attitude compared to physicians. Specialist nurses 
through nurse-based clinics can however play a key role in the effective management of patients with 
a cardiac device35.  
Generalised reluctance to discuss palliative issues, such as deactivation is well recognised 
across all clinical settings and professions. Potential solutions have been suggested including 
additional training4,26, with improved knowledge and skills acquisition27.  An alternative strategy is 
clarification of roles and sharing of the responsibility concerning deactivation, facilitated by a 
multidisciplinary team approach. This approach has been successfully implemented within the 
oncology setting, as patients receiving care from a multidisciplinary team showed an improved 
survival 36 , better patient experience and quality of life37 . 
In summary, our study indicates that the current practice of discussing and deactivating an ICD 
is predominantly a task performed by physicians with minor input from specialist nurses. A paradigm 
shift toward a team-based approach, as routinely used in oncology and palliative medicine, is 
advocated.  
 
Improved inclusion of patients and carers 
The healthcare professionals in this study agreed that patients should be informed about deactivation 
prior to implant and periodically during the disease trajectory, as per clinical guidelines21. Furthermore, 
the decision to deactivate an ICD was deemed to require agreement between the cardiologist, patient 
and his/her family. Healthcare professionals were more confident being involved in such decisions 
when the patient initiates the conversation (M= 9.70 ± 2.03) and/or has the support of family (p=0.014).  
Many professionals value shared decision-making within clinical practice, which required the relay of 
accurate and timely information to ensure individual patient’s preferences inform treatment choices. 
Indeed, studies have shown that patients with an ICD have diverse preferences to discuss ICD 
deactivation14. The scientific statement published by the American Heart Association36 provided a 
“roadmap” to guide discussions and enable shared decision-making, proven to restore hope and 
control over illness experience as perceived by patients and families39. Despite studies advising 
involvement of the family to provide patients’ psychological support and in some cases to act as 
surrogate decision-makers, there is limited evidence of its application in practise. For example, a 
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recent retrospective case note review found only 32% of all palliative discussions had family 
involvement1. 
 Results of a survey carried out on Belgium and Scandinavian nurses (n=425) may provide an 
explanation – while nurses recognised the patient’s family as important to their care, they were 
reluctant to actively invite family members to be involved in the care of the patient40 and 20% agreed 
with the statement “I do not have time to take care of families”. Interestingly the more experienced 
nurse and those nurses from Scandinavian countries possessed a more positive attitude. In summary, 
improved patient and family involvement in patients’ management plan is warranted to facilitate 
shared clinical decision-making through the delivery of patient-centred information and discussion.       
 Limitations of the study include the diverse representation across countries and disciplines, as 
well as the data collection tool. A number of strategies were used to promote recruitment, the most 
effective being a personalised email sent by members of the research team. The innovative survey 
instrument engaged participants as there was a complete dataset from all professionals who 
commenced the survey. Despite scrupulous preparation and refinement, the nine independent 
variables only explained 10% of the variance for likelihood to discuss deactivation and 3% of variance 
concerning professionals’ confidence. Similar effect sizes have been reported in previous professional 
factorial surveys23,24. It is be acknowledged that the nine variables selected may not truly reflect those, 
perhaps more implicit factors professionals’ base their decision whether to discuss deactivation on. 
Nevertheless results strengthen our opinion that healthcare professionals make clinical decisions 
based on a multitude of factors and which could be deemed idiosyncratic.    
 
Conclusion 
 
Decision-making regarding ICD deactivation is complex, multifactorial with lack of a coherent 
multidisciplinary approach to practise internationally. The cross-country variation in attitudes and 
decision-making sparks concern, and confirms that further investigation is warranted on the socio-
cultural issues and interesting interprofessional differences, which may have a bearing on the overall 
European reluctance to initiate a discussion leading to ICD deactivation compared to American 
counterparts. Furthermore, ICD deactivation is an important clinical issue for patients and carers, with 
our findings supporting the value of additional research and development on the regulatory and 
medico-legal considerations of this clinical decision. Nurses play an important role in the care of 
patients with advanced heart disease and their families. Our findings indicate that the nurses’ role in 
supporting effective decision making requires improvement. Advanced communication training and 
clinical mentorship would aid knowledge and skills to ultimately improve the care and reduce suffering 
of palliative patients with an ICD.  
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Table 5: What’s new and implications for practice   
What’s new? Implications for Practice 
1: Five patient factors- ‘Advanced age, 
presence of malignancy, more than 3 hospital 
admissions over previous year, receipt of 
multiple shocks, severe heart failure symptoms 
(NYHA IV)’ increased professional’s likelihood 
to discuss ICD deactivation. 
2: The practise of discussing ICD deactivation 
varies across countries with American, medical 
and nursing professionals were more likely to 
discuss ICD deactivation, in comparison to their 
European colleagues 
3: Nurses are reluctant and lacked confidence 
in discussing ICD deactivation compared to 
physicians.  
1: A multidisciplinary approach is 
necessary to improve the clinical 
management of the discussion and 
decision concerning ICD deactivation. 
 
 2: Innovative educational strategies 
should be developed to improve 
patients’ and family members’ 
understanding of the functionality of 
the ICD 
    
3: Additional training and support 
required for nurses to improve 
involvement in palliative discussions 
that include ICD deactivation  
 
 
 
 
 
 
Appendix 1: Outline of the methodology  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 APPENDICES 
 
 
 
 
Ethical approval  
& contract signed with 
Project Implicit  
Define the research question  
What are the clinical and professional factors that may 
impact on the decision to discuss ICD deactivation? 
 
 
Commence work with Project 
Implicit 
Questionnaire construction: 
(Personal, professional, “last case”, standard vignette) 
Objective One 
Systematic review of the literature 2008-
2014 
Semi-structured interviews with patient 
(n=10) & carers (n=10) 
Create textual vignette and 3 decision questions at the 
end of the vignette 
Objective Three 
Identify Independent variables (IV)  
(n=9) 
Factorial Survey Design 
Preliminary Research 
Validate with clinical experts  
Pre-Test  
Objective Two 
Retrospective case note review Sept 2012-Sept 2013 
Focus groups with clinical team (n=9)    
Confirm links to professional organisations: 
BHF, BCS, ICS, CCNAP 
Statistical data analysis (using SPSS)  
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